PIA
ALNA

Piedmont Investment Advisors’s Allena Pharmaceuticals ALNA Stock Holding History

Piedmont Investment Advisors’s Portfolio ALNA Stock Details ALNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-201
Closed -$3K – 2551
2018
Q2 		$3K Buy
+201
New +$2.9K ﹤0.01% 2473

Other funds holding ALNA

FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
TGI
TRV GP II Boston, Massachusetts $1.34M AUM 67.55% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Piedmont Investment Advisors's ALNA Position: Q3 2018 in Review

Piedmont Investment Advisors sold out of Allena Pharmaceuticals (ALNA) in Q3 2018, closing a stake of 201 shares — an estimated $3K sold.

Piedmont Investment Advisors first reported a position in ALNA in Q2 2018 and held it in 1 quarter. The position peaked at $3K in Q2 2018. 46 funds tracked by Wall St. Rank hold ALNA as of Q3 2018.

  • Piedmont Investment Advisors reported no remaining Allena Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
  • Piedmont Investment Advisors sold 201 Allena Pharmaceuticals shares in Q3 2018, an estimated $3K.
  • Piedmont Investment Advisors first reported a position in Allena Pharmaceuticals in Q2 2018 and held it in 1 quarter.
  • Piedmont Investment Advisors's Allena Pharmaceuticals position peaked at $3K in Q2 2018.
  • 46 funds tracked by Wall St. Rank held Allena Pharmaceuticals as of Q3 2018.

Based on Piedmont Investment Advisors's 13F filing for Q3 2018, filed 8 Nov 2018.